−Removed: Item 2 – Unregistered Sales of Securities and Use of Proceeds
−Removed: On July 28, 2021, the Board of Directors of the Company approved an increase in the value of shares of common stock that may be repurchased under the share repurchase program, up to $1.0 billion.
−Removed: During the three months ended September 30, 2021, the Company had no repurchases of common shares under the program and therefore the newly authorized $1.0 billion remains available as of the end of the period.
+Added: Item 2 – Unregistered Sales of Securities and Use
+Added: During the three months ended June 30, 2022, the Company had the following activity
+Added: with respect to this repurchase program:
+Added: (in millions, except per share amounts)
+Added: Total Number of Shares Purchased
+Added: Average Price Paid Per Share
+Added: Total Cost of Shares Purchased
+Added: Dollar Value of Shares that May
+Added: be Purchased Under the Stock Repurchase Program
+Added: April 1, 2022 to April
+Added: May 1, 2022 to May 31,
+Added: June 1, 2022 to June
+Added: (a) On July 28, 2021 the Board of Directors approved a share repurchase program, up to $1.0 billion.
+Added: On March 8, 2022, the Company entered
+Added: into an ASR Agreement with a financial institution, to repurchase $150 million of the Company’s common stock.
+Added: The final settlement of $30 million of common stock occurred in April 2022.
+Added: For further information see Part I, Item 1, Note 5, Earnings
+Added: Per Common Share, in the Notes to Unaudited Interim Consolidated Financial Statements of this Form 10-Q.
Item 6 – Exhibits
−Removed: Exhibit Number Description
−Removed: Section 302 Certification Statement Chief Executive Officer
−Removed: Section 302 Certification Statement Chief Financial Officer
+Added: Exhibit Number
+Added: Interim Chief Executive Officer Employment Agreement by and between DENTSPLY
+Added: Groetelaars, dated April 16, 2022 (1)
+Added: Interim Chief Financial Officer Employment Agreement by and between DENTSPLY
+Added: and Barbara W.
+Added: Bodem, dated April 16, 2022 (2)
+Added: Dentsply Sirona Inc.
+Added: Key Employee Severance Benefits Plan, dated May 25, 2022 (3)
+Added: Section 302 Certification Statement Chief
+Added: Executive Officer
+Added: Section 302 Certification Statement Chief
+Added: Financial Officer
Section 906 Certification Statements
−Removed: 101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
−Removed: 101.SCH XBRL Taxonomy Extension Schema Document
−Removed: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document
−Removed: 101.LAB XBRL Extension Labels Linkbase Document
−Removed: 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
+Added: XBRL Instance Document - the instance document
+Added: does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
+Added: XBRL Taxonomy Extension Schema Document
+Added: XBRL Taxonomy Extension Calculation Linkbase
+Added: XBRL Taxonomy Extension Definition Linkbase
+Added: XBRL Extension Labels Linkbase Document
+Added: XBRL Taxonomy Extension Presentation Linkbase
+Added: Cover Page Interactive Data File (formatted as
+Added: Inline XBRL and contained in Exhibit 101)
+Added: (1) Incorporated by reference to exhibit included in the Company's Form 8-K, dated April 19, 2022, File no.
+Added: (2) Incorporated by reference to exhibit included in the Company's Form 8-K, dated April 19, 2022, File no.
+Added: (3) Incorporated by reference to exhibit included in the Company's Form 8-K, dated May 31, 2022, File no.
+Added: Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be
+Added: signed on its behalf by the undersigned hereunto duly authorized.
DENTSPLY SIRONA Inc.
−Removed: /s/ Donald M.
November 7, 2022
Chief Executive Officer
−Removed: Gomez November 4, 2021
−Removed: Executive Vice President and
+Added: November 7, 2022
Chief Financial Officer
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.